Targets & Cell Types in Immuno-Oncology on November 14-15, 2023 in Berlin, Germany

Targets & Cell Types in Immuno-Oncology on November 14-15, 2023 in Berlin, Germany

With new & emerging targets and drug candidates in immuno-oncology, key opinion leaders from pharmaceutical & biotech companies as well as academic & research organisations will be presenting on innovative approaches & methods for target identification & validation, such as AI-based strategies, novel checkpoint inhibitors and latest developments & case studies in cellular therapies : TILs, gamma deltas, myeloid cells.

 

Meet key decision markers representing large pharma & biotech companies:

  • Kris Clark, Grey Wolf Therapeutics
  • Stefano Sammicheli, Ichnos Sciences
  • Jorg Rippmann, Boehringer Ingelheim
  • Gregory Vladimer, Exscientia
  • Nisit Khandelwal, iOmx Therapeutics
  • Cecile Bauche, Alaya.bio

& much more!

 

View the agenda: https://www.oxfordglobal.co.uk/immuno-targets-cells/agenda/?utm_source=conferenceindex&utm_medium=eventlisting&utm_campaign=immuno&utm_content=tacell2023

 

Expand your knowledge & discuss future priorities in:

  •     Emerging Technologies, Strategies & Methods for Novel Targets & Target Validation in Immuno-Oncology
  •     Novel Cell Types to Develop Effective IO Therapies

Co-located with Biomarkers Europe 2023 and Precision Oncology Europe 2023, attendees will receive access to all three events. For more information contact [email protected]

Name: Oxford Global
Website: https://www.oxfordglobal.co.uk

Related Events